GGrantIndex
← Leaderboards

Elaine Tuomanen

University Of Alabama At Birmingham

$16,379,473
Attributed
$17,734,233
Total exposure
12
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,734,233 · 12

By mechanism

R01$15,164,049 · 7
U54$1,780,731 · 2
RC1$788,091 · 1
M01$1,362 · 2

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Streptococcus Pneumoniae

Research focus

Streptococcus PneumoniaeCell WallAffectMeningitisPathogenMolecularBiochemicalBrainNeuronsCellsPneumoniaResponsePenicillinsAnimal ModelBacteriaPatternAntibioticsPathway InteractionsSignal TransductionSepsisGrantInfectionApoptosisPneumococcal Infections

Grant awards (53)

Antibiotic tolerance: membraneless organelles and autolysin regulation$455,000
R01 · FY2025 · AI · contact PI
Bioactivities of pneumococcal cell wall in neuropathogenesis$441,350
R01 · FY2025 · AI · contact PI
Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection$644,990
R01 · FY2024 · AI
Antibiotic tolerance: membraneless organelles and autolysin regulation$455,000
R01 · FY2024 · AI · contact PI
Bioactivities of pneumococcal cell wall in neuropathogenesis$455,000
R01 · FY2024 · AI · contact PI
Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection$657,115
R01 · FY2023 · AI
Antibiotic tolerance: membraneless organelles and autolysin regulation$455,000
R01 · FY2023 · AI · contact PI
Bioactivities of pneumococcal cell wall in neuropathogenesis$455,000
R01 · FY2023 · AI · contact PI
Antibiotic tolerance: membraneless organelles and autolysin regulation$455,000
R01 · FY2022 · AI · contact PI
Bioactivities of pneumococcal cell wall in neuropathogenesis$455,000
R01 · FY2022 · AI · contact PI
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients$675,979
R01 · FY2021 · AI
Bioactivities of pneumococcal cell wall in neuropathogenesis$448,750
R01 · FY2021 · AI · contact PI
Multi-center evaluation of the threat of established and emerging respiratory viral infections in pediatric transplant recipients$262,298
R01 · FY2021 · AI
Bioactivities of pneumococcal cell wall in neuropathogenesis$448,750
R01 · FY2020 · AI · contact PI
Bioactivities of pneumococcal cell wall in neuropathogenesis$448,750
R01 · FY2019 · AI · contact PI
Bioactivities of pneumococcal cell wall in neuropathogenesis$448,750
R01 · FY2018 · AI · contact PI
Bioactivities of pneumococcal cell wall in neuropathogenesis$448,750
R01 · FY2017 · AI · contact PI
Bioactivities of Pneumococcal Cell Wall in Meningitis$420,000
R01 · FY2015 · AI · contact PI
Bioactivities of Pneumococcal Cell Wall in Meningitis$420,000
R01 · FY2014 · AI · contact PI
Bioactivities of Pneumococcal Cell Wall in Meningitis$394,800
R01 · FY2013 · AI · contact PI
Bioactivities of Pneumococcal Cell Wall in Meningitis$420,000
R01 · FY2012 · AI · contact PI
Bioactivities of Pneumococcal Cell Wall in Meningitis$420,000
R01 · FY2011 · AI · contact PI
Pathogenesis & molecular epidemiology of Pneumococcal infection in Sickle Cell$204,413
U54 · FY2011 · HL · contact PI
Novel vaccines for otitis media$400,794
RC1 · FY2010 · DC · contact PI
Novel vaccines for otitis media$387,297
RC1 · FY2009 · DC · contact PI
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$348,812
R01 · FY2009 · AI · contact PI
Pathogenesis & molecular epidemiology of Pneumococcal infection in Sickle Cell$304,278
U54 · FY2009 · HL · contact PI
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$348,812
R01 · FY2008 · AI · contact PI
Pathogenesis & molecular epidemiology of Pneumococcal infection in Sickle Cell$305,340
U54 · FY2008 · HL · contact PI
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$355,568
R01 · FY2007 · AI · contact PI
Pathogenesis and Molecular Epidemiology of Pneumococcal Infection in Sickle Cell$243,968
U54 · FY2007 · HL · contact PI
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$366,188
R01 · FY2006 · AI · contact PI
CONTROL OF AUTOLYSIS IN PNEUMOCOCCI$256,332
R01 · FY2006 · AI · contact PI
Pathogenesis and Molecular Epidemiology of Pneumococcal Infection in Sickle Cell$188,769
U54 · FY2006 · HL · contact PI
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$318,750
R01 · FY2005 · AI
CONTROL OF AUTOLYSIS IN PNEUMOCOCCI$262,500
R01 · FY2005 · AI
Pathogenesis and Molecular Epidemiology of Pneumococcal Infection in Sickle Cell$183,275
U54 · FY2005 · HL
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$296,218
R01 · FY2004 · AI
CONTROL OF AUTOLYSIS IN PNEUMOCOCCI$262,500
R01 · FY2004 · AI
Pathogenesis and Molecular Epidemiology of Pneumococcal Infection in Sickle Cell$177,936
U54 · FY2004 · HL
Epidemiology &Genetic Markers for Pneumococcal Tolerance$1,362
M01 · FY2004 · RR
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$289,178
R01 · FY2003 · AI
CONTROL OF AUTOLYSIS IN PNEUMOCOCCI$262,500
R01 · FY2003 · AI
Pathogenesis and Molecular Epidemiology of Pneumococcal Infection in Sickle Cell$172,752
U54 · FY2003 · HL
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$282,343
R01 · FY2002 · AI
CONTROL OF AUTOLYSIS IN PNEUMOCOCCI$262,500
R01 · FY2002 · AI
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$275,706
R01 · FY2001 · AI
CONTROL OF AUTOLYSIS IN PNEUMOCOCCI$184,959
R01 · FY2001 · AI
EPIDEMIOLOGY/ GENETIC MARKERS FOR PNEUMOCOCCAL TOLERANCE$0
M01 · FY2001 · RR
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS$269,262
R01 · FY2000 · AI
CONTROL OF AUTOLYSIS IN PNEUMOCOCCI$179,572
R01 · FY2000 · AI
ADHERENCE OF BORDETELLA PERTUSSIS TO CELLS$157,067
R01 · FY2000 · AI
EPIDEMIOLOGY/ GENETIC MARKERS FOR PNEUMOCOCCAL TOLERANCE$0
M01 · FY2000 · RR